Home News About Activities Fellows Publications Contact
 
 
 

Bero Lisa

E-mail: lisa.bero@sydney.edu.au

Lisa Bero, Ph.D. is Chair of Medicines Use and Health Outcomes at the Charles Perkins Centre, University of Sydney, where she directs the Evidence, Policy and Influence Collaborative (EPIC) Research Group. EPIC has three main areas of research: 1) empirical studies of bias, 2) evidence synthesis, and 3) pharmaceutical policy. Lisa trained in pharmacology and health policy. She relocated to Sydney on 1 August 2014, having been Professor, Institute for Health Policy Studies and Dept Clinical Pharmacy, University of California, San Francisco (UCSF) from 1991?2014. She directs a multidisciplinary team whose primary focus is on ways to produce, synthesize and promote the translation of rigorous and unbiased evidence into health policy and practice. Lisa specializes in studying the quality, use and implications of research for healthcare and health policy, and has both collaborated with and studied as research subjects such diverse groups as policymakers, journalists, consumers, and researchers themselves. She pioneered the development of qualitative and quantitative methods (called ?meta-research?) for measuring bias in the design, conduct and dissemination of both human and animal research on pharmaceuticals, tobacco, chemicals and complex public health interventions. Lisa has a particular interest in biases related to research sponsorship and investigator conflicts of interest. She has published over 200 peer-reviewed articles; the majority of papers have appeared in top journals such as JAMA, BMJ, PLoS Medicine, American Journal of Public Health, as well as law, political science and policy journals. Lisa has held numerous leadership positions in The Cochrane Collaboration, an international organization that conducts evidence synthesis. She was Co-Chair, Cochrane Collaboration Governing Board (2013-2017). She has served on a number of international committees related to conflicts of interest in research, education and practice or evidence synthesis. She was elected to Fellowship in the Collegium Ramazzini in 2017.

Questions? Comments! Mail to: events@ramazzini.it